Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Penny Stocks

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

PharmaTher Presents Positive Data On Ketamine For Treatment Of Dyskinesia In Parkinson’s Disease

By Nicolas Jose Rodriguez
September 17, 6:09 PM
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM), a leader in specialty ketamine pharmaceuticals, announced Friday that the Phase 1/2 clinical study of ketamine in the treatment of levodopa-induced dyskinesia in Parkinson’s disease was presented at the MDS

CSE:PHRM

Read More
1 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

New Batch Of Psilocybin Microdose Capsules Is Ready, Learn All The Details

By Lara Goldstein
September 17, 6:05 PM
Canadian-based psychedelics company Nova Mentis Life Science Corp.

NMLSF

Read More
2 minute read
  • Cannabis
  • Earnings
  • Guidance
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Awakn Shares Its Q2 2022 Results, Showing Consistent Growth On Its Second Full Financial Year

By Lara Goldstein
September 17, 6:01 PM
Biotech firm leading the Alcohol Use Disorder (AUD) treatment Awakn Life Sciences Corp. (OTCQB: AWKNF) has announced its financial outcomes and business highlights for the three months ended July 31, 2022. During the period, numbers reflected:

AWKNF

Read More
2 minute read
  • Cannabis
  • Entrepreneurship
  • General
  • Markets
  • Movers & Shakers
  • News
  • Penny Stocks
  • Small Cap

Former Crime Analyst To Lead Michigan Cannabis Agency & Latest Key Executive Changes In Marijuana Space

By Jelena Martinovic
September 17, 5:29 PM
Former Crime Analyst To Lead Michigan Cannabis Agency

CGC

Read More
3 minute read
  • Long Ideas
  • Penny Stocks
  • Short Ideas
  • Small Cap
  • Trading Ideas

Bulls And Bears Of The Week: Tesla, Apple, Meta, Bitcoin And An Investor Darling Down 70%

By Michael Cohen
September 17, 1:48 PM
Benzinga has examined the prospects for many investors' favorite stocks over the past week, here's a look at some of our top stories. 

AAPL

Read More
1 minute read
  • Penny Stocks

Board of Directors Appointment

By The Newswire
September 17, 7:43 AM
  Vancouver, British Columbia – TheNewswire – September 12, 2022 – Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT)…

CSE:LEXT

Read More
1 minute read
  • Penny Stocks

Changes to the Board of Directors

By The Newswire
September 17, 7:03 AM
   Vancouver, British Columbia – TheNewswire – September 8, 2022. Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF)…

CSE:LEXT

Read More
2 minute read
  • Cannabis
  • Earnings
  • Guidance
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Wellbeing Digital Reports 4Q Finances, ‘Three Key Pillars’ Stay Strong

By Lara Goldstein
September 16, 4:05 PM
Wellbeing Digital Sciences Inc. (OTC: KONEF) filed its financial results for the quarter ended July 31, 2022 and provided some insight on their most recent businesses. Numbers for the selected period showed:

KONEF

Read More
2 minute read
  • News
  • Penny Stocks
  • Small Cap

S&P 500 Suffers Big Weekly Loss As Investors React To More Discouraging Inflation Data

By Wayne Duggan
September 16, 3:34 PM
The SPDR S&P 500 ETF Trust (NYSE: SPY) suffered heavy losses this week following another round of disappointing inflation data.

ACB

Read More
1 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Major Psychedelics Firm Is Studying Magic Mushrooms To Treat Meth Addiction

By Lara Goldstein
September 16, 3:10 PM
Life sciences company Revive Therapeutics Ltd. (OTCQB: RVVTF) is advancing its first Phase I/II clinical trial of oral psilocybin for methamphetamine use disorder treatment while also developing an oral psilocybin thin film strip product.

RVVTF

Posts pagination

Previous 1 … 1,063 1,064 1,065 … 1,231 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service